Clinical Trials Logo

AV Fistula clinical trials

View clinical trials related to AV Fistula.

Filter by:
  • None
  • Page 1

NCT ID: NCT05569109 Not yet recruiting - AV Fistula Clinical Trials

av Fistula Patency Loss as a Cause of Fistula Failure and Hyperphosphatemia

Start date: December 1, 2022
Phase:
Study type: Observational

Assessment of arteriovenous fistula patency loss which leads to av fistula failure and its relation to high serum phosphate level in chronic hemodialysis patients.

NCT ID: NCT05462223 Recruiting - AV Fistula Clinical Trials

Alucent Vessel Restoration System for AVF

Activate AVF
Start date: July 15, 2022
Phase: N/A
Study type: Interventional

Feasibility of the Vessel Restoration System for AVF

NCT ID: NCT04626427 Terminated - Clinical trials for Chronic Kidney Diseases

The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation

WAVE-Global
Start date: December 22, 2020
Phase: N/A
Study type: Interventional

This is a global, multi-center, prospective, post-market, confirmatory, interventional, non-randomized, single-arm clinical investigation evaluating arteriovenous fistula (AVF) creation by means of the WavelinQ™ EndoAVF System in patients who require a vascular access for hemodialysis (HD).

NCT ID: NCT04484220 Active, not recruiting - AV Fistula Clinical Trials

Ellipsys Vascular Access System Post Market Surveillance (PS) Study

Start date: April 13, 2021
Phase: N/A
Study type: Interventional

The proposed clinical study is a prospective, non-randomized, multi-center, single-arm, observational, post-market surveillance (PS) study of the Ellipsys Vascular Access System in subjects eligible for arteriovenous (AV) fistula.

NCT ID: NCT04327609 Active, not recruiting - AV Fistula Clinical Trials

SAVE Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications

SAVE
Start date: April 10, 2020
Phase: N/A
Study type: Interventional

Prospective multi-center single-blinded randomized controlled trial (RCT) investigating the safety and feasibility of the SELUTION SLR™ (Sustained Limus Release) 018 drug eluting balloon (DEB) for the treatment of failed AV fistula in renal dialysis patients. Patients will be randomised to either SELUTION SLR or POBA.

NCT ID: NCT02475837 Completed - AV Fistula Clinical Trials

Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access

Start date: August 26, 2015
Phase: Phase 2
Study type: Interventional

The Objectives of this study are: 1. To determine if vorapaxar safely improves arteriovenous (AV) fistula functional maturation when administered during the maturation process compared with placebo. 2. To determine if vorapaxar safely improves AV fistula patency, allowing for secondary procedures to aid in fistula maturation compared with placebo. 3. To determine if vorapaxar safely facilitates successful cannulation of AV fistulas for hemodialysis compared with placebo. This is a randomized placebo-controlled double-blind pilot trial. Study procedures will be conducted at Stanford University Medical Center, and standard-of-care (SOC) procedures will be conducted at Stanford and it's affiliated hospitals (Veteran's Affairs Palo Alto Health Care System and the Stanford Vascular Surgery Clinic at Valley Medical Center). The investigators expect to enroll 128 patients. Patients will be assigned to treatment groups with a 1:1 randomization in blocks of 4 at the conclusion of the AV fistula creation. Patients will be stratified based on fistula location (lower arm versus upper arm).

NCT ID: NCT02363972 Completed - Clinical trials for End Stage Renal Disease

Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD

Start date: February 10, 2015
Phase: N/A
Study type: Interventional

A prospective single-arm well-controlled study to evaluate the safety and effectiveness of a less invasive means of establishing vascular access to facilitate dialysis in patients with end stage renal disease.

NCT ID: NCT01471041 Completed - Clinical trials for End Stage Renal Disease

Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae

SAVE
Start date: December 2011
Phase: Phase 2/Phase 3
Study type: Interventional

The SAVE Study will evaluate the safety and efficacy of the Venous Window Needle Guide in achieving access of a deep, un-cannulatable arteriovenous fistula to complete hemodialysis as prescribed.